Japan shares end higher as IMF forecast boosts hopes of higher earnings
- Shionogi & Co gained 1.12% after the drug maker said it sold the development and marketing rights for a COVID-19 treatment to California-based biotech BioAge Labs Inc.
TOKYO: Japanese stocks closed higher on Wednesday, on hopes of better corporate results after the International Monetary Fund raised its forecast for global growth, while shares of Nikko Denko jumped following a revision in its earnings outlook.
The Nikkei share average ended 0.31% higher at 28,635.21, while the broader Topix gained 0.65% to 1,860.07.
The International Monetary Fund (IMF) raised its forecast for global economic growth in 2021 and said the coronavirus-triggered downturn last year would be nearly a full percentage point less severe than expected.
"Many of the Japanese stocks are sensitive to the global economy. Investors are taking a fresh look at Japanese shares after the IMF's global economic outlook," said Hideyuki Ishiguro, senior strategist, Daiwa Securities.
Equities in Asia, except Japan, fell, with MSCI's gauge of Asian ex-Japan shares slipping 0.3%.
Back home, electronic components maker Nitto Denko jumped 7.91% to a three-year high, after it raised its annual operating profit forecast to 90 billion yen ($867.89 million). The stock was the top gainer on the Nikkei index, followed by Canon, which jumped 6.71%, and Sharp with a gain of 6.15%.
Shionogi & Co gained 1.12% after the drug maker said it sold the development and marketing rights for a COVID-19 treatment to California-based biotech BioAge Labs Inc.
ANA Holdings fell 0.61% after the airline said it would suspend 16 international routes and reduce service to three other routes during the summer as the COVID-19 pandemic restricts travel around the world.
Energy and environment services firm Japan Asia Group was priced at a limit high of 1,090 yen after the shares were untraded on a glut of buy orders as US buyout fund Carlyle Group increased its offer.
Comments
Comments are closed.